Genesee Capital Advisors’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$848K Buy
2,508
+537
+27% +$172K 0.27% 81
2026
Q1
$596K Sell
1,971
-8
-0.4% -$2.68K 0.25% 72
2025
Q4
$732K Sell
1,979
-17
-0.9% -$6.08K 0.29% 69
2025
Q3
$663K Buy
1,996
+5
+0.3% +$1.59K 0.29% 67
2025
Q2
$635K Buy
1,991
+5
+0.3% +$1.41K 0.28% 71
2025
Q1
$534K Sell
1,986
-25
-1% -$7.39K 0.27% 77
2024
Q4
$597K Buy
2,011
+253
+14% +$72.7K 0.28% 71
2024
Q3
$477K Buy
1,758
+191
+12% +$47.6K 0.23% 81
2024
Q2
$363K Buy
+1,567
New +$363K 0.18% 84

Other funds holding AXP

Genesee Capital Advisors's AXP Position: Q2 2026 in Review

Genesee Capital Advisors increased its American Express (AXP) stake by 27% in Q2 2026, buying an estimated $172K and bringing the position to 2,508 shares worth $848K. The position accounts for 0.27% of the portfolio, ranked #81.

Genesee Capital Advisors first reported a position in AXP in Q2 2024 and has held it in 9 quarters since. 3,007 funds tracked by Wall St. Rank hold AXP as of Q2 2026.

  • Genesee Capital Advisors held 2,508 shares of American Express worth $848K as of Q2 2026.
  • Genesee Capital Advisors bought 537 American Express shares in Q2 2026, an estimated $172K.
  • American Express made up 0.27% of Genesee Capital Advisors's portfolio in Q2 2026, its #81 holding.
  • Genesee Capital Advisors first reported a position in American Express in Q2 2024 and has held it in 9 quarters since.
  • 3,007 funds tracked by Wall St. Rank held American Express as of Q2 2026.

Based on Genesee Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.